Increased risk for malignant neoplasms among patients with cirrhosis.
Kalaitzakis
Evangelos
E
Institute of Internal Medicine, University of Gothenburg, Sahlgrenska Academy, Gothenburg, Sweden. evangelos.kalaitzakis@medicine.gu.se
Gunnarsdottir
Steingerdur Anna
SA
Josefsson
Axel
A
Björnsson
Einar
E
D017677:Age Distribution; D000367:Age Factors; D006528:Carcinoma, Hepatocellular / Q000453:epidemiology / Q000628:therapy; D002423:Cause of Death; D018281:Cholangiocarcinoma / Q000453:epidemiology / Q000628:therapy; D015331:Cohort Studies; D004067:Digestive System Neoplasms / Q000453:epidemiology* / Q000628:therapy; D005260:Female; D019698:Hepatitis C, Chronic / Q000453:epidemiology; D006801:Humans; D015994:Incidence; D008103:Liver Cirrhosis / Q000145:classification / Q000453:epidemiology* / Q000209:etiology; D016031:Liver Transplantation / Q000706:statistics & numerical data; D008175:Lung Neoplasms / Q000453:epidemiology* / Q000628:therapy; D008297:Male; D008875:Middle Aged; D016016:Proportional Hazards Models; D012042:Registries; D018570:Risk Assessment; D012720:Severity of Illness Index; D017678:Sex Distribution; D012737:Sex Factors; D012907:Smoking / Q000453:epidemiology; D016019:Survival Analysis; D013548:Sweden / Q000453:epidemiology